An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies

Human cytomegalovirus (CMV) is a highly prevalent pathogen with ~60%–90% seropositivity in adults. CMV can contribute to organ rejection in transplant recipients and is a major cause of birth defects in newborns. Currently, there are no approved vaccines against CMV. The epitope of a CMV neutralizin...

Descripción completa

Detalles Bibliográficos
Autores principales: Behzadi, Mohammad Amin, Stein, Kathryn R., Bermúdez-González, Maria Carolina, Simon, Viviana, Nachbagauer, Raffael, Tortorella, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630953/
https://www.ncbi.nlm.nih.gov/pubmed/31207917
http://dx.doi.org/10.3390/vaccines7020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630953/
https://www.ncbi.nlm.nih.gov/pubmed/31207917
http://dx.doi.org/10.3390/vaccines7020051

Ejemplares similares